Mesothelioma Cancer Centers
Rush University Cancer Center
Doctors Affiliated with this Treatment Facility
The Rush University Cancer Center, located in Chicago, Illinois, is home to clinics and programs offered by a team of specialists who provide optimal care for patients with cancer. Twenty departments, divisions, and sections are dedicated to serving each individual’s plan of care with comprehensive and leading-edge treatments. The Commission on Cancer (CoC) has approved the various programs at the Rush University Cancer Center.
All cancer related clinics, programs, research efforts, and educational services are worked on at the Rush University Cancer Center. The academic medical center is committed to an elaborate research program that investigates the most effective treatments and therapies. Extensive outpatient and inpatient centers provide multidisciplinary services. Counseling services are offered as well, providing social and emotional therapy to patients and their families.
The Rush University Cancer Center is part of the non-profit medical group including Rush University Medical Center, Rush University, Rush Oak Park Hospital and Rush Health. The Rush University Medical Center received its charter in 1837 making it the longest running health care institution in Chicago. The charter was reactivated in 1969 to further merge with the Presbyterian-St. Luke’s Medical Center. Rush University itself was established in 1972 and currently consists of the colleges of medicine, nursing, health sciences, and research training. The medical college became Illinois’ first educational facility in medicine.
In 2003, the center officially became the Rush University Medical Center. Rush has been adamant about developing treatments that are innovative and effective. The facility has retained a status of excellence; honored with numerous awards in patient care, education, and research for over 170 years. In the 2011 issue of U.S. News & World Report, Rush was ranked in the top fifty of America’s best hospitals.
Mesothelioma Treatment at the Rush University Cancer Center
The Thoracic Oncology Program at the Rush University Cancer Center offers a comprehensive care program for mesothelioma and other malignancies of the chest; including the lungs, esophagus, mediastinum, pleura, trachea, and diaphragm. Board-certified oncologists, pulmonologists, radiologists, radiation oncologists, and surgeons work together as a multidisciplinary team of expert physicians and health care professionals. The thoracic surgeons at Rush have over 70 years of combined experience in their surgical practice and over 15 years in leading-edge laparascopic surgery. They take the most minimally invasive approaches to thoracic cancer treatment. Surgeons are also supported by a team of physician assistants and nurses that bring experience and a depth of knowledge to the center.
Surgeons in the Thoracic Oncology Program are also part of the Coleman Foundation Lung Cancer and Chest Tumor Clinic. This interdisciplinary program provides effective care, comprehensive evaluation, and treatment recommendations based on each patient’s diagnosis and medical history. Physicians determine the severity of each patient’s illness based on the advanced use of diagnostic imaging, biopsy, and analysis. The center offers minimally-invasive diagnostic techniques such as Video-Assisted Thoracoscopic Surgery (VATS) and Endobronchial Ultrasound (EBUS) to achieve accurate results. Mesothelioma and other chest malignancies are treated at the clinic using advanced forms of chemotherapy, radiotherapy, radiation therapy, and other treatments including TomoTherapy, Photodynamic therapy and 4-D simulation.
Michael J. Liptay, M.D. became the director of the Thoracic Surgery Residency Program at the Rush University Medical Center in 2010, and has since been directing the largest thoracic surgery practice in Chicago. He is currently the head of the Division of Thoracic Surgery and the vice chairperson in the Department of Cardiovascular-Thoracic Surgery. Liptay is an associate professor at the Rush Medical College and holds the position as medical director of the Coleman Foundation Chest Tumor Clinic. He has extensive experience with detection, staging, and determining lung cancer prognosis.
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette